Israeli biotech Emedgene has developed a platform that can pinpoint the genetic mutation(s) responsible for rare genetic diseases. Emedgene gets cases from healthcare organizations and uses Artificial Intelligence and information databases to help geneticists uncover the underlying problem.
https://emedgene.com/emedgene-raises-6-million-to-scale-genomics-based-care-with-ai/